Firefly Neuroscience, Inc.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,137.1% | -2,684.2% | -10,991.7% | -57.7% | -7,633.3% | -2,298.1% | -5,839.5% | -799.3% | -383.5% | -438.1% | -401.6% | -340.5% | -388.6% | |
| -747.2% | 0.0% | 0.0% | 0.2% | 12.1% | 111.3% | 44.2% | 14.4% | 14.9% | 12.6% | 9.3% | 9.1% | 11.2% | |
| -649.3% | 357.9% | 491.7% | 3.0% | 7,018.2% | 149.1% | 574.4% | 25.8% | 55.4% | 58.7% | 87.2% | 79.6% | 71.7% | |
| -1,317.9% | 2,626.3% | -2,133.3% | 5.4% | -2,300.0% | 2,560.4% | -1,837.2% | -324.7% | 68.3% | 76.2% | -117.3% | 15.4% | 4.9% | |
| 0.0% | 0.0% | 1,091.7% | 9.5% | 497.0% | 150.9% | 16.3% | 4.0% | 22.2% | 5.6% | 12.0% | 8.2% | 11.6% | |
| -4,069.5% | -2,031.6% | -1,091.7% | -9.5% | -269.7% | -143.4% | -16.3% | -793.3% | -22.2% | -5.6% | -12.0% | -8.2% | -11.6% | |
| – | – | – | – | – | – | – | – | -4.9% | – | – | – | – | |
| 7,270.5% | 11,294.7% | 7,875.0% | -60.1% | 10,545.5% | 3,535.8% | 23,844.2% | 379.6% | -4.9% | 60.7% | 492.0% | 1,535.2% | 584.1% | |
| 2,343.0% | 6,662.1% | -4,208.3% | -67.2% | 2,642.4% | 1,094.3% | 17,988.4% | -1,213.0% | -410.6% | -383.0% | 78.4% | 1,186.6% | 183.9% | |
| 2,137.1% | -2,684.2% | -12,083.3% | -67.2% | -8,130.3% | -2,449.1% | -5,855.8% | -803.3% | -405.7% | -443.7% | -413.6% | -348.6% | -400.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.